Search results for "Globin"

showing 10 items of 734 documents

A New Type of Artificial Oxygen Carrier: Soluble Hyperpolymeric Haemoglobin with Negligible Oncotic Pressure—Production of Thermally Stable Hyperpoly…

1992

Oncotic pressureChromatographyHuman bloodTemperaturechemistry.chemical_elementGeneral MedicineOxygenMolecular WeightOxygenHemoglobinschemistry.chemical_compoundCross-Linking ReagentsDrug StabilitySolubilitychemistryBlood SubstitutesGlutaralOsmotic PressureHumansOrganic chemistryGlutaraldehydeCross linkerBiomaterials, Artificial Cells and Immobilization Biotechnology
researchProduct

Molar masses and structure in solution of haemoglobin hyperpolymers--a common calibration of size exclusion chromatography of these artificial oxygen…

1997

We are developing artificial oxygen carriers for medical use, based on synthetic polymers--so-called hyperpolymers--obtained by cross-linking mammalian haemoglobins. One requirement with respect to the polymers is that they should not increase the oncotic pressure of blood remarkably--this can be realized by high molecular weights of the polymers with a narrow distribution. They may act as a oxygen transporting blood additive, and--in combination with a plasma expander--as a blood substitute. Another important and desired property of the artificial oxygen carrier is a low viscosity, which--first--is due to a high degree of uniformity of the polymer size (or molar mass) distribution and--sec…

Oncotic pressurePolymersSwineSize-exclusion chromatographyBiomedical EngineeringAnalytical chemistrychemistry.chemical_elementengineering.materialOxygenBlood substituteGel permeation chromatographyHemoglobinsBlood SubstitutesAnimalsHumanschemistry.chemical_classificationChromatographyMolar massMolecular StructureViscosityPolymerMolecular WeightCross-Linking ReagentschemistryengineeringChromatography GelCattleBiopolymerBiotechnologyArtificial cells, blood substitutes, and immobilization biotechnology
researchProduct

Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes.

2019

BACKGROUND Establishing cardiovascular safety of new therapies for type 2 diabetes is important. Safety data are available for the subcutaneous form of the glucagon-like peptide-1 receptor agonist semaglutide but are needed for oral semaglutide. METHODS We assessed cardiovascular outcomes of once-daily oral semaglutide in an event-driven, randomized, double-blind, placebo-controlled trial involving patients at high cardiovascular risk (age of ≥50 years with established cardiovascular or chronic kidney disease, or age of ≥60 years with cardiovascular risk factors only). The primary outcome in a time-to-event analysis was the first occurrence of a major adverse cardiovascular event (death fro…

OralMaleRiskGlucagon-Like PeptideGlycated Hemoglobin AGlucagon-Like PeptidesAdministration OralGlucagon-Like Peptide-1 ReceptorSettore MED/13 - EndocrinologiaAll institutes and research themes of the Radboud University Medical CenterDouble-Blind MethodCardiovascular DiseaseDiabetes MellitusHumansHypoglycemic AgentsSettore MED/49 - Scienze Tecniche Dietetiche ApplicateAgedGlycated HemoglobinHypoglycemic AgentMetabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6]General MedicineMiddle AgedAdministration Oral; Aged; Cardiovascular Diseases; Diabetes Mellitus Type 2; Double-Blind Method; Female; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Glycated Hemoglobin A; Humans; Hypoglycemic Agents; Male; Middle Aged; RiskDiabetes Mellitus Type 2Cardiovascular DiseasesAdministrationFemaleType 2Human
researchProduct

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

2015

BACKGROUND: Data are lacking on the long-term effect on cardiovascular events of adding sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and cardiovascular disease. METHODS: In this randomized, double-blind study, we assigned 14,671 patients to add either sitagliptin or placebo to their existing therapy. Open-label use of antihyperglycemic therapy was encouraged as required, aimed at reaching individually appropriate glycemic targets in all patients. To determine whether sitagliptin was noninferior to placebo, we used a relative risk of 1.3 as the marginal upper boundary. The primary cardiovascular outcome was a composite of cardiovascular deat…

Oralmedicine.medical_specialtyHeart diseasesGlycosylatedAdministration Oralheart failureType 2 diabetesDipeptidyl peptidase-4 inhibitorKaplan-Meier EstimatePlaceboSitagliptin PhosphateSitagliptin Cardiovascular Outcomeschemistry.chemical_compoundDrug TherapyDouble-Blind MethodInternal medicineDiabetes MellitusmedicineHumansHypoglycemic AgentsGlycated HemoglobinHemoglobin A GlycosylatedAdministration Oral; Cardiovascular Diseases; Diabetes Mellitus Type 2; Double-Blind Method; Drug Therapy Combination; Follow-Up Studies; Heart Diseases; Heart Failure; Hemoglobin A Glycosylated; Hospitalization; Humans; Hypoglycemic Agents; Kaplan-Meier Estimate; Pyrazines; Sitagliptin Phosphate; Triazoles; Medicine (all)business.industryMedicine (all)SemaglutideSitagliptin PhosphateHemoglobin AGeneral MedicineTriazolesta3121medicine.diseaseSurgeryHospitalizationCardiovascular diseaseschemistryDiabetes Mellitus Type 2SitagliptinPyrazinesAdministrationCombinationDrug Therapy CombinationGlycated hemoglobinbusinessType 2Alogliptinmedicine.drugFollow-Up StudiesNew England Journal of Medicine
researchProduct

Proteins in Saccharides Matrices and the Trehalose Peculiarity: Biochemical and Biophysical Properties

2015

Immobilization of proteins and other biomolecules in saccharide matrices leads to a series of peculiar properties that are relevant from the point of view of both biochemistry and biophysics, and have important implications on related fields such as food industry, pharmaceutics, and medicine. In the last years, the properties of biomolecules embedded into glassy matrices and/or highly concentrated solutions of saccharides have been thoroughly investigated, at the molecular level, through in vivo, in vitro, and in silico studies. These systems show an outstanding ability to protect biostructures against stress conditions; various mechanisms appear to be at the basis of such bioprotection, th…

Organic Chemistrytrehalose protein dynamics biopreservation myoglobinSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Current Organic Chemistry
researchProduct

Low Viscosity of Densely and Highly Polymerized Human Hemoglobin in Aqueous Solution — the Problem Of Stability

1989

In case of chronic and acute tissue oxygen deficit it is of advantage to have an artificial oxygen carrying blood substitute in order to support a least temporarily blood function. From a physico-chemical point of view an artificial oxygen carrying blood substitute must meet 4 main requirements at the desired concentration.

Oxygen-carryingAqueous solutionPolymerizationChemical engineeringChemistryPolymer chemistryTissue oxygenHemoglobinBlood substituteBlood function
researchProduct

Pre‐exercise whole‐body cooling decreases blood volume and oxygenated hemoglobin content in skeletal muscle during submaximal exercise (1106.7)

2014

Oxygenated Hemoglobinmedicine.medical_specialtybusiness.industrySkeletal muscleBlood volumeSubmaximal exerciseBiochemistryPre exercisemedicine.anatomical_structureInternal medicineGeneticsmedicineCardiologyPhysical therapyWhole bodybusinessMolecular BiologyBiotechnologyThe FASEB Journal
researchProduct

Carbohydrate quality changes and concurrent changes in cardiovascular risk factors: a longitudinal analysis in the PREDIMED-Plus randomized trial.

2020

[Background]: Overall quality of dietary carbohydrate intake rather than total carbohydrate intake may determine the risk of cardiovascular disease (CVD).

PREDIMED-Plus carbohydrate carbohydrate quality index cardiovascular disease fiber glycemic index obesity randomized controlled trialsMaleobesity030309 nutrition & dieteticsMedicine (miscellaneous)030204 cardiovascular system & hematologyOverweightchemistry.chemical_compound0302 clinical medicinecardiovascular diseaseRisk FactorsSurveys and QuestionnairesGlycemic indexLongitudinal StudiesProspective Studies2. Zero hunger0303 health sciencesNutrition and DieteticsMiddle AgedCardiovascular disease3. Good healthGlycemic indexCardiovascular Diseasesrandomized controlled trialsRandomized controlled trialsFemalemedicine.symptomfibermedicine.medical_specialtyWaistCarbohydrates03 medical and health sciencesInternal medicinemedicineDietary CarbohydratesHumansFiberObesityAgedCarbohydrate quality indexTriglyceridebusiness.industryPREDIMED-PlusOverweightmedicine.diseaseObesityDietBlood pressurechemistrycarbohydratecarbohydrate quality indexglycemic indexGlycated hemoglobinMetabolic syndromebusinessEnergy Intake
researchProduct

Myoglobin, expressed in brown adipose tissue of mice, regulates the content and activity of mitochondria and lipid droplets

2021

Abstract The identification of novel physiological regulators that stimulate energy expenditure through brown adipose tissue (BAT) activity in substrate catalysis is of utmost importance to understand and treat metabolic diseases. Myoglobin (MB), known to store or transport oxygen in heart and skeletal muscles, has recently been found to bind fatty acids with physiological constants in its oxygenated form (i.e., MBO2). Here, we investigated the in vivo effect of MB expression on BAT activity. In particular, we studied mitochondrial function and lipid metabolism as essential determinants of energy expenditure in this tissue. We show in a MB-null (MBko) mouse model that MB expression in BAT i…

PalmitatesOxidative phosphorylationMitochondrion1307 Cell BiologyMiceAdipose Tissue BrownLipid dropletBrown adipose tissueRespiration1312 Molecular BiologymedicineAnimalsHumansPPAR alpha11434 Center for Clinical StudiesMuscle SkeletalMolecular BiologyUncoupling Protein 1Mice KnockoutMyoglobinChemistryProteinsThermogenesisLipid metabolismLipid DropletsCell BiologyMetabolism10081 Institute of Veterinary PhysiologyPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaMitochondriaCell biologyOxygenDisease Models AnimalAdipocytes Brownmedicine.anatomical_structure10076 Center for Integrative Human Physiology570 Life sciences; biologyApoptosis Regulatory ProteinsEnergy MetabolismThermogenesisBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
researchProduct

Effects of Acute Handling Stress on Whitefish Coregonus lavaretus After Prolonged Exposure to Biologically Treated and Untreated Bleached Kraft Mill …

2000

Exposure of fish to water of impaired quality has been shown to disrupt the function of the hypothalamo-pituitary-interrenal (HPI) axis and alter the interpretation of data from field studies due to the varying effects of handling and delayed sampling on exposed and reference animals. In the present study, juvenile whitefish, Coregonus lavaretus, were exposed for 6 weeks to diluted (4-8%) untreated and biologically treated bleached kraft mill effluent (BKME) and their response to acute handling was investigated. Liver microsomal EROD activity and glycogen phosphorylase (GPase) activity, in addition to gill Na+-K+-ATPase activity, and blood hemoglobin and hematocrit levels were increased in …

Papermedicine.medical_specialtyTime FactorsPhosphorylasesHealth Toxicology and MutagenesisBiologyHematocritToxicologyWaste Disposal FluidSpecimen HandlingHemoglobinsGlycogen phosphorylasechemistry.chemical_compoundfoodCoregonus lavaretusInternal medicineCytochrome P-450 CYP1A1medicineAnimalsAnimal HusbandrySalmonidaeGlycogenmedicine.diagnostic_testfood.dishFishesReproducibility of ResultsGeneral Medicinebiology.organism_classificationPollutionRed blood cellEndocrinologymedicine.anatomical_structureHematocritchemistryEnzyme InductionToxicityHemoglobinWater Pollutants ChemicalArchives of Environmental Contamination and Toxicology
researchProduct